EBR:BTLS - Euronext Brussels - BE0974386188 - Common Stock - Currency: EUR
EBR:BTLS (6/4/2025, 7:00:00 PM)
4.16
+0.16 (+4%)
The current stock price of BTLS.BR is 4.16 EUR. In the past month the price increased by 29.6%. In the past year, price increased by 38.67%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
YAR.OL | YARA INTERNATIONAL ASA | 14.52 | 94.79B | ||
SDF.DE | K+S AG-REG | 1666 | 2.98B | ||
1SDF.MI | K+S AG-REG | 49.63 | 2.84B | ||
OCI.AS | OCI NV | N/A | 1.64B | ||
ALFLO.PA | FLORENTAISE SA | N/A | 7.42M |
Biotalys NV engages in the development of sustainable crop protection products. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 63 full-time employees. The company went IPO on 2021-07-02. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. The company develops technology for sustainable crop protection. The company offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. The company also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.
BIOTALYS NV
Buchtenstraat 11
Ghent OOST-VLAANDEREN BE
Employees: 75
Phone: 3292745400
The current stock price of BTLS.BR is 4.16 EUR. The price increased by 4% in the last trading session.
The exchange symbol of BIOTALYS NV is BTLS and it is listed on the Euronext Brussels exchange.
BTLS.BR stock is listed on the Euronext Brussels exchange.
8 analysts have analysed BTLS.BR and the average price target is 6.58 EUR. This implies a price increase of 58.15% is expected in the next year compared to the current price of 4.16. Check the BIOTALYS NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.
BIOTALYS NV (BTLS.BR) has a market capitalization of 155.88M EUR. This makes BTLS.BR a Micro Cap stock.
BIOTALYS NV (BTLS.BR) currently has 75 employees.
BIOTALYS NV (BTLS.BR) has a support level at 3.21. Check the full technical report for a detailed analysis of BTLS.BR support and resistance levels.
The Revenue of BIOTALYS NV (BTLS.BR) is expected to decline by -60% in the next year. Check the estimates tab for more information on the BTLS.BR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BTLS.BR does not pay a dividend.
BIOTALYS NV (BTLS.BR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.4).
ChartMill assigns a technical rating of 9 / 10 to BTLS.BR. When comparing the yearly performance of all stocks, BTLS.BR is one of the better performing stocks in the market, outperforming 96.29% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to BTLS.BR. The financial health of BTLS.BR is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months BTLS.BR reported a non-GAAP Earnings per Share(EPS) of -0.4. The EPS increased by 38.92% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -35.89% | ||
ROE | -47.77% | ||
Debt/Equity | 0.13 |
ChartMill assigns a Buy % Consensus number of 88% to BTLS.BR. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -111.84% and a revenue growth -60% for BTLS.BR